Swiss National Bank - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 62 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$1,054,359
+23.4%
60,7000.0%0.00%0.0%
Q2 2023$854,656
+18.4%
60,700
-9.5%
0.00%
Q1 2023$721,996
-35.7%
67,100
-10.4%
0.00%
-100.0%
Q4 2022$1,122,002
+20.9%
74,900
+3.6%
0.00%0.0%
Q3 2022$928,000
+32.4%
72,3000.0%0.00%
Q2 2022$701,000
+17.4%
72,300
+20.3%
0.00%
Q1 2022$597,000
-3.9%
60,100
+13.8%
0.00%
Q4 2021$621,000
+3.3%
52,8000.0%0.00%
Q3 2021$601,000
-18.3%
52,8000.0%0.00%
Q2 2021$736,000
-26.6%
52,800
-2.6%
0.00%
-100.0%
Q1 2021$1,003,000
+8.1%
54,200
+3.2%
0.00%0.0%
Q4 2020$928,000
+15.4%
52,5000.0%0.00%0.0%
Q3 2020$804,000
-18.3%
52,500
+36.0%
0.00%0.0%
Q2 2020$984,000
+492.8%
38,600
+97.9%
0.00%
Q3 2019$166,000
-37.1%
19,5000.0%0.00%
Q2 2019$264,00019,5000.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders